Zimmer Biomet Holdings ZBH
NYSE ZBH
$94.98 +0.76 (+0.81%)
As of: Sep 9, 2026 · 2:36 PM EDT

Zimmer Biomet Holdings (ZBH) Income from Discontinued Operations (2021 - 2022)

Zimmer Biomet Holdings (ZBH) posted Income from Discontinued Operations of -$58.8 million for Q1 2022, down 101.37% on a QoQ basis from -$29.2 million in Q4 2021, and down 1351.06% year-over-year from $4.7 million in Q1 2021.

Analysis

Zimmer Biomet Holdings (ZBH) Income from Discontinued Operations (2021 - 2022) Analysis & Trends

Zimmer Biomet Holdings has reported Income from Discontinued Operations for 2 years, with the latest figure at -$58.8 million in Q1 2022.

  • On a quarterly basis, Income from Discontinued Operations fell 1351.06% year-over-year to -$58.8 million in Q1 2022; TTM through Dec 2022 was -$58.8 million, a 35.48% decrease from a year earlier, with the FY2022 full-year figure at -$58.8 million, down 35.48% from the prior year.
  • Income from Discontinued Operations was -$58.8 million for Q1 2022 at Zimmer Biomet Holdings, down from -$29.2 million in the prior quarter.
  • The five-year high for Income from Discontinued Operations was $4.7 million in Q1 2021, with the low at -$58.8 million in Q1 2022.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Income (Discontinued) (Qtr)
1 Abbott Laboratories 183.63 Bn 178.03 Bn 7.27 Bn -
2 Intuitive Surgical 124.13 Bn 118.91 Bn 1.96 Bn -
3 Medtronic 118.51 Bn 109.69 Bn 6.34 Bn -
4 Stryker 106.53 Bn 103.06 Bn 4.50 Bn -
5 Boston Scientific 66.52 Bn 65.98 Bn 3.85 Bn -
6 Edwards Lifesciences 49.57 Bn 45.32 Bn 1.35 Bn -
7 Alcon 34.00 Bn 32.55 Bn 1.68 Bn -
8 Dexcom 32.03 Bn 30.08 Bn 830.00 Mn -
9 Steris 21.12 Bn 20.64 Bn 684.20 Mn -
10 Zimmer Biomet Holdings 18.27 Bn 17.86 Bn 1.54 Bn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2022 -58.80 Mn
Dec 31, 2021 -29.20 Mn
Sep 30, 2021 -16.60 Mn
Jun 30, 2021 -2.30 Mn
Mar 31, 2021 4.70 Mn